Posted by Michael Wonder on 23 Jan 2022
Thousands to benefit from decision to subsidise eczema treatment
23 January 2022 - Australians suffering from a severe form of eczema will save tens of thousands of dollars after a new listing on the Pharmaceutical Benefits Scheme.
Rinvoq reduces itching and flare-ups by blocking enzymes that create signals in the body's immune system, resulting in inflammation.
